Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma

Alpha-Fetoprotein Combined with Radiographic Tumor Burden Score to Predict Overall Survival after Liver Resection in Hepatocellular Carcinoma

We evaluated whether combining the radiographic tumor burden score (TBS) and alpha-fetoprotein (AFP) level could be used to stratify overall survival (OS) among hepatocellular carcinoma (HCC) patients after liver resection (LR). Patients who underwent LR for Barcelona Clinic Liver Cancer stage 0, A,...

Full description

Bibliographic Details
Main Authors:	Yi-Hao Yen, Yueh-Wei Liu, Wei-Feng Li, Chih-Chi Wang, Chee-Chien Yong, Chih-Che Lin, Chih-Yun Lin
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Cancers
Subjects:	tumor burden score hepatocellular carcinoma alpha-fetoprotein liver resection
Online Access:	https://www.mdpi.com/2072-6694/15/4/1203

Similar Items

Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients
by: Kong-Ying Lin, et al.
Published: (2023-12-01)

Stationary Trend in Elevated Serum Alpha-Fetoprotein Level in Hepatocellular Carcinoma Patients
by: Yi-Hao Yen, et al.
Published: (2023-02-01)

Nomograms to predict the long‐time prognosis in patients with alpha‐fetoprotein negative hepatocellular carcinoma following radical resection
by: Jian Huang, et al.
Published: (2020-04-01)

Early Detection of Hepatocellular Carcinoma Recurrence Using the Highly Sensitive Fucosylated Fraction of Alpha-Fetoprotein
by: Toru Setsu, et al.
Published: (2017-03-01)

The Emerging Influences of Alpha-Fetoprotein in the Tumorigenesis and Progression of Hepatocellular Carcinoma
by: Ye Xu, et al.
Published: (2021-10-01)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
by: Jin-Chiao Lee, et al.
Published: (2021-08-01)

Clinical value of alpha-fetoprotein: alpha-fetoprotein-L3 isoform ratio and des-γ-carboxyprothrombin in early diagnosis of HBV-related hepatocellular carcinoma
by: Duan Jianping, Du Lei, Song Ting, Liu Zhensheng
Published: (2023-08-01)

Diagnostic value of alpha-fetoprotein combined with neutrophil-to-lymphocyte ratio for hepatocellular carcinoma
by: Jian Hu, et al.
Published: (2018-12-01)

HEPATOCELLULAR CARCINOMA: CORRELATION OF ALPHA-FETOPROTEIN WITH TUMOUR CHARACTERISTICS
by: Rafi Ud Din, et al.
Published: (2020-04-01)

Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma
by: Chengkai Yang, et al.
Published: (2023-04-01)

Evaluation of alpha-fetoprotein as a screening marker for hepatocellular carcinoma in hepatitis prevalent areas
by: Sejong Chun, et al.
Published: (2015-11-01)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
by: Jianping Sun, et al.
Published: (2019-10-01)

Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
by: Brianna Ruch, et al.
Published: (2022-10-01)

Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area
by: Joo Hyun Oh, et al.
Published: (2023-12-01)

Serum exosomal microRNAs combined with alpha‐fetoprotein as diagnostic markers of hepatocellular carcinoma
by: Yurong Wang, et al.
Published: (2018-05-01)

Prognostic role of alpha-fetoprotein in patients with hepatocellular carcinoma treated with repeat transarterial chemoembolisation
by: Gauri Mishra, et al.
Published: (2020-05-01)

Serum alpha-fetoprotein response as a preoperative prognostic indicator in unresectable hepatocellular carcinoma with salvage hepatectomy following conversion therapy: a multicenter retrospective study
by: Kong-Ying Lin, et al.
Published: (2024-02-01)

Correlation of Abdominal CT scan Score and Alpha-fetoprotein Levels in Hepatocellular Carcinoma
by: Indira Prawita Martani, et al.
Published: (2022-09-01)

Comparison of surgical resection and transarterial chemoembolization for patients with intermediate stage hepatocellular carcinoma
by: Chih-Lin Lin, et al.
Published: (2016-06-01)

Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor
by: Dae Hoon Kim, et al.
Published: (2018-11-01)

The outcomes and prognostic factors of patients with hepatocellular carcinoma and normal serum alpha fetoprotein levels
by: Chia-Chu Fu, et al.
Published: (2023-07-01)

α-Fetoprotein, α-Fetoprotein-L3, and Des-γ-Carboxy Prothrombin Stratify Hepatocellular Carcinoma Treatment Response and Progression Risk
by: Kelley Núñez, et al.
Published: (2024-01-01)

Association of Postoperative Biomarker Response with Recurrence and Survival in Patients with Hepatocellular Carcinoma and High Alpha-Fetoprotein Expressions (>400 ng/ml)
by: Liang L, et al.
Published: (2021-03-01)

Application of Machine Learning Techniques to Assess Alpha-Fetoprotein at Diagnosis of Hepatocellular Carcinoma
by: Sergio Gil-Rojas, et al.
Published: (2024-02-01)

A novel prognostic model based on AFP, tumor burden score and Albumin-Bilirubin grade for patients with hepatocellular carcinoma undergoing radiofrequency ablation
by: Jingzhi Huang, et al.
Published: (2023-12-01)

ASSOCIATION OF SERUM ALPHA FETOPROTEIN (AFP) LEVELS WITH SIZE OF HEPATOCELLULAR CARSINOMA
by: Khawar Sahbbir, et al.
Published: (2019-02-01)

Tumor necrosis factor-alpha and alpha-fetoprotein as biomarkers for diagnosis and follow-up of hepatocellular carcinoma before and after interventional therapy
by: Amr Elrabat, et al.
Published: (2019-01-01)

Subtle Hepatocellular Carcinoma: A Persisting Role for Alpha-Fetoprotein Monitoring in High-Risk Patients with Cirrhosis
by: Barry Schlansky, et al.
Published: (2011-10-01)

The Characteristics and Prognosis of Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin Double-Negative Hepatocellular Carcinoma at Baseline in Higher BCLC Stages
by: Takakazu Nagahara, et al.
Published: (2023-01-01)

Alpha-Fetoprotein (AFP): Solved and Unsolved Problems
by: Garry Abelev, et al.
Published: (2020-12-01)

Alpha-Fetoprotein Response after First Transarterial Chemoembolization (TACE) and Complete Pathologic Response in Patients with Hepatocellular Cancer
by: Łukasz Masior, et al.
Published: (2023-08-01)

Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?
by: Ming-Wei Lai, et al.
Published: (2019-03-01)

Raised Alpha-Fetoprotein Level and its Association with Hepatocellular Carcinoma
by: Madiha Hashmi, et al.
Published: (2023-10-01)

A case of alpha-fetoprotein-producing esophageal adenocarcinoma
by: Yi-Yu Chen, et al.
Published: (2013-02-01)

An Extremely Rare Presentation of an Alpha-Fetoprotein-Producing Esophageal Adenocarcinoma
by: Yaser Khalid, et al.
Published: (2020-10-01)

ASSOCIATION BETWEEN ALPHA-FETOPROTEIN AND OTHER SEROLOGICAL MARKERS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: ONE CENTER'S EXPERIENCE
by: Lejla Mehinović, et al.
Published: (2018-09-01)

Prognostic Values of Alpha-Fetoprotein and Des-Gamma-Carboxyprothrombin in Hepatocellular Carcinoma in China: An Analysis of 4792 Patients
by: Pan YX, et al.
Published: (2021-06-01)

Diagnostic sensitivity of arginase, alpha-1 antitrypsin and alpha-fetoprotein in hepatitis patients
by: Hala A. Abdelgaid, et al.
Published: (2021-12-01)

Sunflower-Like Nanostructure with Built-In Hotspots for Alpha-Fetoprotein Detection
by: Xiaoyu Zhao, et al.
Published: (2021-02-01)

Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications
by: Shu-Hsien Liao, et al.
Published: (2017-09-01)